九洲药业跌2.02%，成交额1.39亿元，主力资金净流出2534.89万元

Core Viewpoint - Jiuzhou Pharmaceutical's stock has experienced fluctuations, with a year-to-date increase of 46.97% but a recent decline of 2.02% on October 17, 2023 [1] Financial Performance - For the period from January to September 2025, Jiuzhou Pharmaceutical achieved a revenue of 4.16 billion yuan, representing a year-on-year growth of 4.92%, and a net profit attributable to shareholders of 748 million yuan, which is an 18.51% increase compared to the previous year [2] - Cumulative cash dividends since the company's A-share listing amount to 2.183 billion yuan, with 1.245 billion yuan distributed over the last three years [3] Shareholder Information - As of September 30, 2025, the number of Jiuzhou Pharmaceutical's shareholders increased by 10.22% to 59,200, while the average circulating shares per person decreased by 9.27% to 15,035 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 20.368 million shares, an increase of 7.8125 million shares from the previous period [3]